KMI169
Product Specifications
Target
Epigenetic Reader Domain
Related Pathways
Chromatin/Epigenetic
Bioactivity
KMI169 is a potent and selective bisubstrate inhibitor targeting KMT9's SAM and substrate binding pockets. KMT9 monomethylates histone H4 at lysine 12 and regulates the proliferation of prostate cancer cells. KMI169 can be utilized for research in prostate cancer.
Molecular Formula
C31H31Cl2N7O2
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
055047-01 10 µg
Aldolase C, Fructose Bisphosphate (ALDOC), Recombinant, Human, His-Tag
Sign In for Pricing
View Details 055047-02 50 µg
Aldolase C, Fructose Bisphosphate (ALDOC), Recombinant, Human, His-Tag
Sign In for Pricing
View Details 055047-03 100 µg
Aldolase C, Fructose Bisphosphate (ALDOC), Recombinant, Human, His-Tag
Sign In for Pricing
View Details 055047-04 200 µg
Aldolase C, Fructose Bisphosphate (ALDOC), Recombinant, Human, His-Tag
Sign In for Pricing
View Details